These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19078864)

  • 1. CRP and statins for primary prevention of coronary artery disease.
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):97-8; quiz p following 104. PubMed ID: 19078864
    [No Abstract]   [Full Text] [Related]  

  • 2. [C-reactive protein and coronary heart disease: quo vadis?].
    März W; Grammer TB
    MMW Fortschr Med; 2009 Oct; 151 Suppl 3():127-32. PubMed ID: 20623940
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials and tribulations. Cholesterol veers off script.
    Couzin J
    Science; 2008 Oct; 322(5899):220-3. PubMed ID: 18845747
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Celik M; Celik T
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):253; author reply 253-4. PubMed ID: 19520663
    [No Abstract]   [Full Text] [Related]  

  • 5. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of statins in protecting against ventricular arrhythmias.
    Abinader EG
    Am J Cardiol; 2006 Jan; 97(1):153-4. PubMed ID: 16377305
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of C-reactive protein (CRP) and statin treatment in reducing cardiovascular risk.
    Chin J
    S D Med; 2009 Mar; 62(3):104-6. PubMed ID: 19480274
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protective effects of pravastatin against atherosclerosis in children with familial hypercholesterolemia].
    Riesen WF
    Rev Med Suisse; 2005 Mar; 1(9):649. PubMed ID: 15813344
    [No Abstract]   [Full Text] [Related]  

  • 9. Subclinical atherosclerosis as a target of therapy: potential role of statins.
    Kastelein JJ; Stroes ES; de Groot E
    Am J Cardiol; 2004 Mar; 93(6):737-40. PubMed ID: 15019880
    [No Abstract]   [Full Text] [Related]  

  • 10. The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).
    O'Keefe JH; Carter MD; Lavie CJ; Bell DS
    Postgrad Med; 2009 May; 121(3):113-8. PubMed ID: 19491548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The JUPITER trial: How will it change clinical practice?
    Watson KE
    Rev Cardiovasc Med; 2009; 10(2):91-6. PubMed ID: 19593321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein, coronary risk, and statins.
    Harv Womens Health Watch; 2001 Sep; 9(1):2. PubMed ID: 11572835
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary prevention.
    Smith ER
    Can J Cardiol; 2004 Nov; 20(13):1373-4. PubMed ID: 15565204
    [No Abstract]   [Full Text] [Related]  

  • 14. [The JUPITER study].
    Gaspardone A; Maseri A
    G Ital Cardiol (Rome); 2009 May; 10(5):267-70. PubMed ID: 19537439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Statins inhibit inflammatory reaction. CRP advances as a marker of coronary risk].
    MMW Fortschr Med; 2000 Jul; 142(28-29):54-5. PubMed ID: 10959166
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statins in coronary patients: a solved issue?].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57 Suppl 1():16-23. PubMed ID: 18472029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of statins in overall prevention and treatment of coronary artery disease].
    Ye P
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(40):2812-4. PubMed ID: 16324332
    [No Abstract]   [Full Text] [Related]  

  • 20. Statin therapy for prevention of coronary artery disease. The earlier the better or the longer the better?
    Holdaas H
    Eur Heart J; 2008 Feb; 29(4):425-6. PubMed ID: 18276612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.